MALVERN, Pa., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen will present at the 2023 Cell & Gene Meeting on the Mesa being held October 10-12, 2023 in Carlsbad, CA at the Park Hyatt Aviara Resort.
Dr. Musunuri will provide an overview of Ocugen's clinical development programs, including the business strategy across its unique gene and cell therapy platforms, anticipated milestones, and more detail about the Company's recent positive Phase 1/2 OCU400 data results.
Details of the presentation are as follows:
Event: | 2023 Cell & Gene Meeting on the Mesa |
Date & Time: | October 11, 2023 at 5:15 PM, PDT |
Location: | Park Hyatt Aviara Resort, Carlsbad, CA, Aseptic Technologies Ballroom |
"The Cell & Gene Meeting on the Mesa ...